|
US2017067846A1
|
|
Method and system to derive glycemic patterns from clustering of glucose data
|
|
US2015275179A1
|
|
Methods for producing single pluripotent stem cells and differentiation thereof
|
|
AU2015203087A1
|
|
System and method for measuring an analyte in a sample
|
|
AU2015202434A1
|
|
Analyte testing method and system
|
|
AU2015200504A1
|
|
Analyte measurement and management device and associated methods
|
|
KR20160105481A
|
|
Methods, systems, and devices for optimal positioning of sensors
|
|
AU2014201623A1
|
|
Pluripotent stem cell culture
|
|
AU2014200166A1
|
|
Differentiation of human embryonic stem cells
|
|
US2015168205A1
|
|
Devices, systems and methods to determine area sensor
|
|
US2015157792A1
|
|
Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing
|
|
AU2013263743A1
|
|
Systems and methods of discriminating control solution from a physiological sample
|
|
CN104620246A
|
|
Method and system to indicate glycemic impacts of insulin infusion pump commands
|
|
CA2880019A1
|
|
Method and system to manage diabetes using multiple risk indicators for a person with diabetes
|
|
TW201417774A
|
|
Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
|
|
US2015006087A1
|
|
Analyte meter with operational range configuration technique
|
|
US2014379360A1
|
|
Low glucose treatment for people with diabetes
|
|
US2014379358A1
|
|
Insertion-site decision-support systems and methods
|
|
TW201439742A
|
|
Electronics device with deep power conservation mode via direct or generated signal application and method for employing such an electronics device
|
|
AU2013202702A1
|
|
System and method for measuring an analyte in a sample
|
|
AU2013202489A1
|
|
A method for creating cell clusters
|
